Search for: All records

Abstract The transition from conventional to more regenerative cropping systems can be economically risky due to variable transition period yields and unforeseen costs. We compared yields and economic returns for the first 3 years of the transition from a business as usual (BAU) conventional corn (Zea mays)–soybean (Glycine max) rotation to an aspirational (ASP) five‐crop (corn‐soybean‐winter wheat [Triticum aestivum]–winter canola [Brassica napus]‐forage) rotation in the Upper Midwest United States. Regenerative ASP cropping practices included the more diverse crop rotation, continuous no‐till, cover crops, precision inputs, and livestock (compost) integration. For the first two transition years, BAU corn yields were 8%–12% higher than ASP while in the third transition year, BAU corn yields were 5% lower. Soybean yields were similar for the first 2 years but higher in BAU in the third year due to an ASP pest outbreak. Equivalent yields for other ASP crops were lower than BAU in the first 2 years but similar in the third year except for canola, which suffered from slug damage. Whole‐system economic returns narrowed across years; by year three, whole system comparisons for the ASP corn and soybean entry points (corn‐soybean‐wheat and soybean‐wheat‐canola, respectively) showed equivalent economic returns for BAU and ASP, despite yield differences, owing largely to the ASP system's reduced operational costs. Overall findings suggest that early regenerative systems can be as profitable as conventional systems with careful attention to rotation entry points and inputs. 

Abstract Inadequate oxygenation is a major challenge in cell encapsulation, a therapy which holds potential to treat many diseases including type I diabetes. In such systems, cellular oxygen (O 2 ) delivery is limited to slow passive diffusion from transplantation sites through the poorly O 2 -soluble encapsulating matrix, usually a hydrogel. This constrains the maximum permitted distance between the encapsulated cells and host site to within a few hundred micrometers to ensure cellular function. Inspired by the natural gas-phase tracheal O 2 delivery system of insects, we present herein the design of a biomimetic scaffold featuring internal continuous air channels endowed with 10,000-fold higher O 2 diffusivity than hydrogels. We incorporate the scaffold into a bulk hydrogel containing cells, which facilitates rapid O 2 transport through the whole system to cells several millimeters away from the device-host boundary. A computational model, validated by in vitro analysis, predicts that cells and islets maintain high viability even in a thick (6.6 mm) device. Finally, the therapeutic potential of the device is demonstrated through the correction of diabetes in immunocompetent mice using rat islets for over 6 months. 

Cell encapsulation represents a promising therapeutic strategy for many hormone-deficient diseases such as type 1 diabetes (T1D). However, adequate oxygenation of the encapsulated cells remains a challenge, especially in the poorly oxygenated subcutaneous site. Here, we present an encapsulation system that generates oxygen (O2) for the cells from their own waste product, carbon dioxide (CO2), in a self-regulated (i.e., “inverse breathing”) way. We leveraged a gas-solid (CO2–lithium peroxide) reaction that was completely separated from the aqueous cellular environment by a gas permeable membrane. O2 measurements and imaging validated CO2-responsive O2 release, which improved cell survival in hypoxic conditions. Simulation-guided optimization yielded a device that restored normoglycemia of immunocompetent diabetic mice for over 3 months. Furthermore, functional islets were observed in scaled-up device implants in minipigs retrieved after 2 months. This inverse breathing device provides a potential system to support long-term cell function in the clinically attractive subcutaneous site.